Percutaneous transpedicular vertebroplasty with polymethyl methacrylate for pathological fracture of the spine

Kuan Yu Chen, Hsin I. Ma, Yung Hsiao Chiang

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We aimed to evaluate the safety and therapeutic efficacy of percutaneous transpedicular vertebroplasty (PVP) using polymethyl methacrylate (PMMA) in patients with symptomatic metastatic spine lesions. We included 31 patients in this retrospective study who were treated with PMMA from 2003 to 2005 for intractable pain due to metastatic spine lesions. The types of cancer (and numbers of patients) included: lung cancer (9), breast cancer (7), gastrointestinal (GI) tract cancers (5), hepatobiliary malignancies (3), and other types of cancer (7). All patients received vertebroplasty, resulting in 41 treatments (16 in thoracic, 25 in lumbar spine). Preoperative and postoperative visual analog scale (VAS) scores for pain were measured in all patients. Image studies including contrast-enhanced MRI were performed in all patients. Results showed characteristic metastatic lesions. Suspicious lesions were further confirmed as malignant by a bone scan, a positron emission tomography (PET) scan, and pathological exam. Vertebroplasty resulted in complete or partial pain relief in 29 patients (95%), and provided no pain relief in 2 patients (5%). The mean preoperative VAS score of 8.9 (±0.93) was higher than the mean postoperative VAS score (2.6 ± 1.71). Metastatic spine lesions were most common in lung and breast cancer patients and these lesions were located more often on segments T12 to L2 (53.6%). Patients with malignancy of hepatobiliary origin did not show improvement in pain scores as dramatically as patients with other types of malignancies, although only a few cases were included in this study. No patients experienced worsening of symptoms or suffered from vertebroplasty complications. We conclude that vertebroplasty is a safe, effective, and simple treatment for the management of intractable spinal pain due to metastases. Crown

Original languageEnglish
Pages (from-to)1300-1304
Number of pages5
JournalJournal of Clinical Neuroscience
Volume16
Issue number10
DOIs
Publication statusPublished - Oct 2009
Externally publishedYes

Fingerprint

Vertebroplasty
Spontaneous Fractures
Polymethyl Methacrylate
Spine
Intractable Pain
Gastrointestinal Neoplasms
Neoplasms
Breast Neoplasms
Visual Analog Scale
Pain
Lung Neoplasms
Pain Measurement
Crowns
Positron-Emission Tomography

Keywords

  • Pathological fracture
  • Percutaneous transpedicular vertebroplasty
  • Quality of life
  • Spine
  • Visual analog scale

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Physiology (medical)

Cite this

Percutaneous transpedicular vertebroplasty with polymethyl methacrylate for pathological fracture of the spine. / Chen, Kuan Yu; Ma, Hsin I.; Chiang, Yung Hsiao.

In: Journal of Clinical Neuroscience, Vol. 16, No. 10, 10.2009, p. 1300-1304.

Research output: Contribution to journalArticle

@article{1df318223b264056829517fc8f7a4944,
title = "Percutaneous transpedicular vertebroplasty with polymethyl methacrylate for pathological fracture of the spine",
abstract = "We aimed to evaluate the safety and therapeutic efficacy of percutaneous transpedicular vertebroplasty (PVP) using polymethyl methacrylate (PMMA) in patients with symptomatic metastatic spine lesions. We included 31 patients in this retrospective study who were treated with PMMA from 2003 to 2005 for intractable pain due to metastatic spine lesions. The types of cancer (and numbers of patients) included: lung cancer (9), breast cancer (7), gastrointestinal (GI) tract cancers (5), hepatobiliary malignancies (3), and other types of cancer (7). All patients received vertebroplasty, resulting in 41 treatments (16 in thoracic, 25 in lumbar spine). Preoperative and postoperative visual analog scale (VAS) scores for pain were measured in all patients. Image studies including contrast-enhanced MRI were performed in all patients. Results showed characteristic metastatic lesions. Suspicious lesions were further confirmed as malignant by a bone scan, a positron emission tomography (PET) scan, and pathological exam. Vertebroplasty resulted in complete or partial pain relief in 29 patients (95{\%}), and provided no pain relief in 2 patients (5{\%}). The mean preoperative VAS score of 8.9 (±0.93) was higher than the mean postoperative VAS score (2.6 ± 1.71). Metastatic spine lesions were most common in lung and breast cancer patients and these lesions were located more often on segments T12 to L2 (53.6{\%}). Patients with malignancy of hepatobiliary origin did not show improvement in pain scores as dramatically as patients with other types of malignancies, although only a few cases were included in this study. No patients experienced worsening of symptoms or suffered from vertebroplasty complications. We conclude that vertebroplasty is a safe, effective, and simple treatment for the management of intractable spinal pain due to metastases. Crown",
keywords = "Pathological fracture, Percutaneous transpedicular vertebroplasty, Quality of life, Spine, Visual analog scale",
author = "Chen, {Kuan Yu} and Ma, {Hsin I.} and Chiang, {Yung Hsiao}",
year = "2009",
month = "10",
doi = "10.1016/j.jocn.2007.12.017",
language = "English",
volume = "16",
pages = "1300--1304",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",
number = "10",

}

TY - JOUR

T1 - Percutaneous transpedicular vertebroplasty with polymethyl methacrylate for pathological fracture of the spine

AU - Chen, Kuan Yu

AU - Ma, Hsin I.

AU - Chiang, Yung Hsiao

PY - 2009/10

Y1 - 2009/10

N2 - We aimed to evaluate the safety and therapeutic efficacy of percutaneous transpedicular vertebroplasty (PVP) using polymethyl methacrylate (PMMA) in patients with symptomatic metastatic spine lesions. We included 31 patients in this retrospective study who were treated with PMMA from 2003 to 2005 for intractable pain due to metastatic spine lesions. The types of cancer (and numbers of patients) included: lung cancer (9), breast cancer (7), gastrointestinal (GI) tract cancers (5), hepatobiliary malignancies (3), and other types of cancer (7). All patients received vertebroplasty, resulting in 41 treatments (16 in thoracic, 25 in lumbar spine). Preoperative and postoperative visual analog scale (VAS) scores for pain were measured in all patients. Image studies including contrast-enhanced MRI were performed in all patients. Results showed characteristic metastatic lesions. Suspicious lesions were further confirmed as malignant by a bone scan, a positron emission tomography (PET) scan, and pathological exam. Vertebroplasty resulted in complete or partial pain relief in 29 patients (95%), and provided no pain relief in 2 patients (5%). The mean preoperative VAS score of 8.9 (±0.93) was higher than the mean postoperative VAS score (2.6 ± 1.71). Metastatic spine lesions were most common in lung and breast cancer patients and these lesions were located more often on segments T12 to L2 (53.6%). Patients with malignancy of hepatobiliary origin did not show improvement in pain scores as dramatically as patients with other types of malignancies, although only a few cases were included in this study. No patients experienced worsening of symptoms or suffered from vertebroplasty complications. We conclude that vertebroplasty is a safe, effective, and simple treatment for the management of intractable spinal pain due to metastases. Crown

AB - We aimed to evaluate the safety and therapeutic efficacy of percutaneous transpedicular vertebroplasty (PVP) using polymethyl methacrylate (PMMA) in patients with symptomatic metastatic spine lesions. We included 31 patients in this retrospective study who were treated with PMMA from 2003 to 2005 for intractable pain due to metastatic spine lesions. The types of cancer (and numbers of patients) included: lung cancer (9), breast cancer (7), gastrointestinal (GI) tract cancers (5), hepatobiliary malignancies (3), and other types of cancer (7). All patients received vertebroplasty, resulting in 41 treatments (16 in thoracic, 25 in lumbar spine). Preoperative and postoperative visual analog scale (VAS) scores for pain were measured in all patients. Image studies including contrast-enhanced MRI were performed in all patients. Results showed characteristic metastatic lesions. Suspicious lesions were further confirmed as malignant by a bone scan, a positron emission tomography (PET) scan, and pathological exam. Vertebroplasty resulted in complete or partial pain relief in 29 patients (95%), and provided no pain relief in 2 patients (5%). The mean preoperative VAS score of 8.9 (±0.93) was higher than the mean postoperative VAS score (2.6 ± 1.71). Metastatic spine lesions were most common in lung and breast cancer patients and these lesions were located more often on segments T12 to L2 (53.6%). Patients with malignancy of hepatobiliary origin did not show improvement in pain scores as dramatically as patients with other types of malignancies, although only a few cases were included in this study. No patients experienced worsening of symptoms or suffered from vertebroplasty complications. We conclude that vertebroplasty is a safe, effective, and simple treatment for the management of intractable spinal pain due to metastases. Crown

KW - Pathological fracture

KW - Percutaneous transpedicular vertebroplasty

KW - Quality of life

KW - Spine

KW - Visual analog scale

UR - http://www.scopus.com/inward/record.url?scp=69049116105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69049116105&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2007.12.017

DO - 10.1016/j.jocn.2007.12.017

M3 - Article

C2 - 19556132

AN - SCOPUS:69049116105

VL - 16

SP - 1300

EP - 1304

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

IS - 10

ER -